How Much Does Spironolactone Cost in Virginia in 2026?

Virginia Cash Prices for Spironolactone in 2026

The average cash price for generic spironolactone at Virginia retail pharmacies sits near $15 per month in 2026. That figure covers a standard 30-day supply of 50 mg or 100 mg tablets dispensed at chains like CVS, Walgreens, and Kroger locations across the commonwealth.

Pfizer's branded Aldactone carries a manufacturer list price of approximately $80 per month, but almost no one pays that amount. Generic spironolactone has been available since 2002, and competition among manufacturers (Teva, Mylan, Accord Healthcare, and others) keeps the actual transaction price low. A 2020 cross-sectional analysis of U.S. prescription drug pricing found that generic medications with five or more manufacturers typically cost 83% less than their branded equivalents. Spironolactone fits that pattern.

Prices vary by pharmacy. Costco and Walmart pharmacies in the Richmond, Virginia Beach, and Northern Virginia markets often dispense 30 tablets of spironolactone 100 mg for $4 to $9 without insurance. Independent pharmacies may charge $18 to $25. The spread is wide enough that calling two or three pharmacies before filling a prescription can save $10 or more per month.

Discount platforms like GoodRx, RxSaver, and Amazon Pharmacy apply negotiated rates at participating Virginia locations. These programs frequently bring a 30-day supply below $10 even at higher-priced chains. No insurance is required. The discount card simply replaces the pharmacy's default cash price with a pre-negotiated rate.

Does Virginia Medicaid Cover Spironolactone?

Yes. Virginia Medicaid covers spironolactone, but the program requires prior authorization for certain indications. The prior authorization step exists because spironolactone's most common dermatologic uses (hormonal acne, hirsutism) are off-label.

Virginia expanded Medicaid enrollment under the Affordable Care Act in 2019, adding roughly 500,000 adults to the program. The Virginia Department of Medical Assistance Services (DMAS) manages the preferred drug list. Generic spironolactone appears on the Virginia Medicaid formulary, and once prior authorization is granted, the enrollee copay is typically $0 to $4 per prescription.

Prior authorization for dermatologic indications generally requires documentation that the patient has tried and failed at least one topical retinoid or topical antibiotic. A prescribing clinician submits a PA request form through the pharmacy benefit manager (currently Magellan Rx for Virginia's fee-for-service population, though managed care organizations like Aetna Better Health of Virginia and Anthem HealthKeepers may use their own PA workflows). Approval typically takes 24 to 72 hours.

For heart failure and fluid retention, the FDA-approved indications, prior authorization is rarely needed. The American Heart Association's 2022 heart failure guidelines list mineralocorticoid receptor antagonists (including spironolactone) as a Class I recommendation for patients with heart failure with reduced ejection fraction, making coverage straightforward.

Commercial Insurance Coverage Across Virginia

Most Virginia commercial insurance plans place generic spironolactone on Tier 1 or Tier 2 of their formularies. Copays range from $0 (with plans that waive generic copays entirely) to $15 per month.

Large employers in Northern Virginia, the Hampton Roads corridor, and the Richmond metro area typically contract with Anthem, CareFirst BlueCross BlueShield, Aetna, Cigna, or UnitedHealthcare. All five carriers include generic spironolactone on their standard formularies without step therapy requirements when prescribed for FDA-approved indications.

Off-label prescribing for acne can trigger a coverage review. Some plans flag spironolactone claims coded with acne-related ICD-10 codes (L70.0 through L70.9) and request clinical documentation. A practical workaround: if a patient also has a diagnosis of hypertension, fluid retention, or hyperaldosteronism, the prescriber can use that as the primary indication. This is clinically appropriate when the diagnosis is accurate, not a coding manipulation.

Layton et al. published a 2017 systematic review in the British Journal of Dermatology examining spironolactone's efficacy in female acne. The review found consistent evidence of benefit at doses between 50 mg and 200 mg daily, though the authors noted the absence of large randomized controlled trials at that time. Insurers have slowly expanded coverage for acne use as the evidence base has grown.

The Virginia State Corporation Commission's Bureau of Insurance does not mandate coverage of specific drugs but does require that health plans sold on the Virginia exchange cover the ACA's ten essential health benefit categories, which include prescription drugs. Generic spironolactone meets the minimum formulary requirements under every Virginia exchange plan filed for 2026.

Compounded Spironolactone in Virginia

Compounded spironolactone is legal and available in Virginia through licensed 503A pharmacies. A 503A pharmacy compounds medications pursuant to individual patient prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act, as outlined by the FDA.

Virginia compounding pharmacies can prepare spironolactone in non-standard dosage forms: topical creams (typically 5% concentration), suspensions for patients who cannot swallow tablets, and custom-dose capsules. Topical spironolactone applied directly to acne-prone skin avoids most systemic side effects (breast tenderness, menstrual irregularity, potassium elevation) while delivering the drug to androgen receptors in the sebaceous gland.

A small open-label study published in the Journal of the American Academy of Dermatology found that topical spironolactone 5% cream reduced inflammatory lesion counts by 50% over 20 weeks in female patients with moderate acne. The sample was limited (N=40), and the study lacked a placebo arm, so the evidence remains preliminary.

Compounded topical spironolactone prices in Virginia range from $30 to $75 per month, depending on the pharmacy, concentration, and base formulation. This is more expensive than oral generic tablets, so compounded formulations make the most sense for patients who experience intolerable systemic side effects on oral dosing or who have a specific clinical reason to use a topical route.

Virginia's Board of Pharmacy regulates 503A compounding facilities and conducts inspections for compliance with USP 795 (nonsterile compounding) and USP 797 (sterile compounding) standards. Patients can verify a pharmacy's compounding license through the Virginia Board of Pharmacy's online license lookup tool.

Telehealth Access to Spironolactone in Virginia

Virginia permits telehealth prescribing of spironolactone. The state passed HB 2070 in 2020, permanently authorizing audio-video telehealth visits and requiring commercial insurers and Medicaid to reimburse them at the same rate as in-person visits. A prescriber licensed in Virginia (or holding a Virginia telemedicine license) can evaluate a patient via video, diagnose hormonal acne, and transmit a spironolactone prescription to any Virginia pharmacy.

Several national telehealth dermatology platforms operate in Virginia: Apostrophe, Curology, Dear Brightly, and others. HealthRX also provides telehealth consultations with board-certified clinicians who can prescribe spironolactone and coordinate lab monitoring (a baseline metabolic panel is recommended within the first month of therapy, per Endocrine Society clinical guidance).

The telehealth visit itself typically costs $30 to $75 without insurance. Combined with the $15 average monthly cost of generic spironolactone, a Virginia patient can initiate and maintain treatment for under $100 in the first month and under $20 per month thereafter.

One clinical requirement that telehealth does not eliminate: potassium monitoring. Spironolactone is a potassium-sparing diuretic. Hyperkalemia (serum potassium above 5.0 mEq/L) is the most clinically significant adverse effect, occurring in approximately 2% to 5% of patients taking 50 to 100 mg daily for acne. Patients need a blood draw at a local lab (Quest, Labcorp, or a hospital outpatient lab) at baseline and again at 4 to 6 weeks. Telehealth platforms that skip this step are cutting a medically important corner.

Discount Programs and Savings Strategies

Virginia residents have several paths to reduce spironolactone costs below the $15 average cash price.

Manufacturer savings cards. Pfizer does not offer a savings card for branded Aldactone since the drug lost patent exclusivity decades ago. However, some generic manufacturers run periodic promotions through pharmacy benefit aggregators. These are inconsistent and not worth relying on.

Pharmacy discount programs. Walmart's $4 generic list includes spironolactone 25 mg and 50 mg (30-day supply). Costco Pharmacy, which does not require a Costco membership to use, prices spironolactone 100 mg at $5 to $8 for 30 tablets at Virginia locations. Kroger's Rx Savings Club ($36 per year for individuals, $72 for families) includes spironolactone at $0 copay for a 30-day supply.

State assistance programs. Virginia's Prescription Drug Assistance Program provides limited help for uninsured residents whose income falls between 138% and 300% of the federal poverty level, the gap population that earns too much for Medicaid but struggles with out-of-pocket costs. Eligibility varies by drug; spironolactone's low price means the program's value here is marginal compared to its benefit for expensive biologics.

340B pharmacies. Federally qualified health centers and safety-net hospitals in Virginia purchase drugs at 340B pricing, which is 25% to 50% below wholesale acquisition cost. Patients treated at a 340B-eligible facility (such as a community health center in Richmond or Norfolk) may receive spironolactone at no cost or minimal copay regardless of insurance status.

Mail-order pharmacies. Amazon Pharmacy, Mark Cuban's Cost Plus Drugs, and traditional PBM mail-order services (Express Scripts, OptumRx, Caremark) all ship to Virginia addresses. Cost Plus Drugs prices spironolactone at manufacturer cost plus a flat 15% markup plus a $5 dispensing fee, landing at roughly $5 to $7 per month for a 30-day supply.

Who Should Consider Spironolactone for Acne in Virginia

Spironolactone is prescribed off-label for hormonal acne in women and is not approved for acne in men due to anti-androgenic side effects (gynecomastia, decreased libido). The typical candidate is a woman over age 18 with inflammatory acne concentrated along the jawline, chin, and lower face, a distribution pattern consistent with androgen-mediated sebum overproduction.

The American Academy of Dermatology's 2024 acne management guidelines include spironolactone as a recommended option for adult female patients with moderate to severe acne who have not responded adequately to topical therapy. Starting doses are 25 mg to 50 mg daily, titrated to 100 mg to 200 mg daily based on response and tolerability.

A retrospective cohort study of 6,330 women prescribed spironolactone for acne found that 66.1% remained on therapy at 12 months, a retention rate significantly higher than oral antibiotics (48.2% at 12 months in the same dataset). The high retention suggests that patients find the drug both effective and tolerable enough to continue.

Contraindications include pregnancy (FDA Category X; spironolactone can feminize a male fetus), renal insufficiency (eGFR <30 mL/min), hyperkalemia, Addison's disease, and concurrent use of other potassium-sparing agents or potassium supplements without close monitoring. Women of childbearing potential should use reliable contraception. Many dermatologists co-prescribe an oral contraceptive for dual benefit: contraception plus additional androgen suppression.

What to Expect: Timeline and Monitoring

Spironolactone takes time. Most patients see initial improvement at 6 to 8 weeks, with full benefit at 3 to 6 months. This is slower than isotretinoin (which often shows results by week 4) but faster than most topical regimens.

Lab monitoring protocol for acne dosing: check a basic metabolic panel (BMP) at baseline, repeat at 4 to 6 weeks after initiation, and then annually if potassium remains normal. If the dose exceeds 100 mg daily or the patient has any renal risk factor (diabetes, NSAID use, ACE inhibitor co-prescription), check potassium every 3 to 6 months.

The Endocrine Society recommends against routine potassium monitoring in young, otherwise healthy women on low-dose spironolactone (25 to 50 mg), citing the extremely low hyperkalemia incidence in this population. Many Virginia clinicians still check at least one baseline panel for medicolegal safety, which is reasonable.

A Virginia patient initiating spironolactone for acne via telehealth can expect the following costs in year one: telehealth visit ($30 to $75), baseline BMP ($15 to $45 at a cash-pay lab), 12 months of generic spironolactone ($48 to $180 depending on dose and pharmacy), and one follow-up BMP ($15 to $45). Total first-year cost without insurance: $108 to $345. With commercial insurance, total out-of-pocket drops to $0 to $60 for most patients.

Serum potassium at baseline should be below 5.0 mEq/L before starting therapy, and prescribers should recheck within 4 to 6 weeks of any dose increase above 100 mg daily.